2-(1-Benzyl-1H-pyrazol-4-yl)-isonicotinic acid
- $45 - $1697
- Product name: 2-(1-Benzyl-1H-pyrazol-4-yl)-isonicotinic acid
- CAS: 893723-63-2
- MF: C10H7NO2S
- MW: 205.23
- EINECS:
- MDL Number:MFCD06496474
- Synonyms:5-(Furan-2-yl)-nicotinic acid;5-(Furan-3-yl)-nicotinic acid;5-(Thiophen-3-yl)-nicotinic acid;2-(1H-Pyrazol-4-yl)-isonicotinic acid;2-(1-Methyl-1H-pyrazol-4-yl)-isonicotinic acid;2-(5-Formylfuran-2-yl)-isonicotinic acid;2-(5-Methylfuran-2-yl)-isonicotinic acid;2-(Furan-2-yl)-isonicotinic acid
4 prices
Selected condition:
Brand
- AK Scientific
- Chemenu
- Crysdot
- TRC
Package
- 10mg
- 1g
- 5g
- ManufacturerAK Scientific
- Product numberV8790
- Product description2-(thiophen-3-yl)isonicotinicacid
- Packaging5g
- Price$1697
- Updated2021-12-16
- Buy
- ManufacturerChemenu
- Product numberCM314457
- Product description2-(Thiophen-3-yl)-isonicotinicacid 95%
- Packaging1g
- Price$489
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11026915
- Product description2-(Thiophen-3-yl)-isonicotinicacid 95+%
- Packaging1g
- Price$518
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberB588295
- Product description2-(thiophen-3-yl)isonicotinicAcid
- Packaging10mg
- Price$45
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
AK Scientific | V8790 | 2-(thiophen-3-yl)isonicotinicacid | 5g | $1697 | 2021-12-16 | Buy |
Chemenu | CM314457 | 2-(Thiophen-3-yl)-isonicotinicacid 95% | 1g | $489 | 2021-12-16 | Buy |
Crysdot | CD11026915 | 2-(Thiophen-3-yl)-isonicotinicacid 95+% | 1g | $518 | 2021-12-16 | Buy |
TRC | B588295 | 2-(thiophen-3-yl)isonicotinicAcid | 10mg | $45 | 2021-12-16 | Buy |
Properties
Boiling point :451.1±35.0 °C(Predicted)
Density :1.368±0.06 g/cm3(Predicted)
pka :1.92±0.10(Predicted)
Density :1.368±0.06 g/cm3(Predicted)
pka :1.92±0.10(Predicted)
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|